🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-06-12
Trial ID
NCT04155580
The primary purpose of the study is to assess safety, and to identify the r...
Status
Terminated
Location
City of Hope Site #151
Start Date
2023-02-22
Trial ID
NCT05403450
Treatments Being Tested
This early-phase trial tests the safety and side effects of a tolinapant gi...
Status
Active Not Recruiting
Location
Emory University/Winship Cancer Institute
Start Date
2022-02-17
Trial ID
NCT05245682
Treatments Being Tested
This is a multi-centre Phase I dose finding and proof-of-concept study of t...
Status
Active Not Recruiting
Location
Cambridge University Hospitals NHS Trust
Start Date
2022-03-02
Trial ID
NCT05082259
Treatments Being Tested
This phase I/II trial tests the safety, best dose and effectiveness of addi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-10-31
Trial ID
NCT06393751
Phase 1 (dose-escalation part): Investigate the tolerability and safety of ...
Status
Terminated
Location
Yamagata University Hospital
Start Date
2020-07-14
Trial ID
NCT04362007
This is an open-label, dose-escalation Phase 1/2 study to assess the safety...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2015-07-14
Trial ID
NCT02503423
Treatments Being Tested
This is a Phase 1, single-dose, open-label, randomized, three-period, three...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2020-07-20
Trial ID
NCT04479800
Treatments Being Tested
Compare two arms: * Chemotherapy followed by tolinapant (ASTX660) in combi...
Status
Recruiting
Location
Centre Léon Bérard
Start Date
2023-12-19
Trial ID
NCT05912075
This phase I/Ib trial tests the safety, side effects, best dose, and effect...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-08-04
Trial ID
NCT06590558